m+Medelevator.RU
← Поиск публикаций
Oral diseases · 2026

Efficacy of Physical Therapy on Maximal Mouth Opening in Patients Affected by Disc Displacement and Degenerative Temporomandibular Joint Diseases: A Systematic Review.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ferrillo Martina, De Rosa Alfredo, Quinzi Vincenzo, Conte Chiara, Francica Antonio, Ammendolia Antonio, Giudice Amerigo, de Sire Alessandro

Аннотация

BACKGROUND: Among temporomandibular disorders (TMDs), the main arthrogenic entities are disc-condylar complex disorders and degenerative diseases.

OBJECTIVE: This systematic review aimed to evaluate the effectiveness of physiotherapy in patients with temporomandibular joint (TMJ) disorders.

METHODS: A systematic review was conducted across PubMed, Scopus, and Web of Science until January 2026 to search for studies including patients with a diagnosis of intracapsular TMD as participants; physical therapy or physical therapy combined to other conservative approaches as intervention; placebo, sham treatments, oral pharmacological anti-inflammatory drugs, behavioral therapy, or other conservative approaches as comparison; maximal mouth opening (MMO) as outcome.

RESULTS: Out of 1578 identified records, 10 studies were included. A total of 354 subjects were analyzed, of which 213 performed a rehabilitation technique and 141 were included in the control group. Although the randomized trials reported improvement in MMO, pain, and function, a major limitation was the lack of standardized physiotherapy protocols across trials.

CONCLUSION: Findings from the present systematic review showed that physiotherapy (active and passive jaw exercises, associated with relaxation techniques) might improve MMO. Further studies with uniform protocols and high-quality randomized trials are needed to validate the efficacy of multimodal treatments in arthrogenic TMD subtypes.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты